|
|
|
|
Assistant Secretary for Planning and Evaluation |
|
WORKING GROUP ON THE NBAC REPORT:
RESEARCH INVOLVING PERSONS WITH MENTAL DISORDERS
THAT MAY AFFECT DECISIONMAKING CAPACITY
Kristina Borror
Office of the Director
National Institutes of Health
Ileana Dominguez-Urban, Executive Secretary and Principal Author
Greenwald Foundation Post-Doctoral Fellow in Bioethics and Health Policy
Visiting Scholar
Office of the Assistant Secretary for Planning and Evaluation
Office of the Secretary
Agnes Donahue
Office of Intergovernmental Affairs
Office of the Secretary
Gary Ellis
Office of Protection from Research Risks
National Institutes of Health
Lily Engstrom
Office of the Assistant Secretary for Planning and Evaluation
Office of the Secretary
Kate-Louise Gottfried
Office of Public Health and Science
Office of the Secretary
Robert Lanman
NIH Legal Advisor
Office of the General Counsel
Bonnie Lee
Office of Regulatory Affairs
Food and Drug Administration
Leo Luberecki
Office of the Assistant Secretary for Legislation
Office of the Secretary
Kate MacQueen
Office of the Director
Centers for Disease Control and Prevention
Charlotte Mullican
Center for Outcomes and Effectiveness Research
Agency for Healthcare Research and Quality
Stuart Nightingale
Office of the Assistant Secretary for Planning and Evaluation
Office of the Secretary
Tom Puglisi
Office of Protection from Research Risks
National Institutes of Health
William Raub, Chair
Office of the Assistant Secretary for Planning and Evaluation
Office of the Secretary
Richard Riseberg
Chief Counsel, U.S. Public Health Service
Office of the General Counsel
Michele K. Russell-Einhorn
Office of Protection from Research Risks
National Institutes of Health
Carole Schauer
Center for Mental Health Services
Substance Abuse and Mental Health Services Administration
Marjorie Speers
Office of the Director
Centers for Disease Control and Prevention
Robert Temple
Center for Drug Evaluation & Research
Food and Drug Administration
The Working Group thanks Dr. Charles McCarthy, former Director of the Office for Protection from Research Risks, and Dr. David Shore, National Institute of Mental Health, for providing important background information regarding regulatory considerations and decisionmaking capacity assessment, respectively.